Lou Gehrig, after 2,130 consecutive games of graceful ... but then progress rapidly. The disease is most often fatal within 5 years of diagnosis. Oosthuyse and colleagues 4 used a targeted ...
Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
The money goes to improving the lives of those with amyotrophic lateral sclerosis, or Lou Gehrig's disease. The disease attacks nerve cells in the brain and spinal cord, resulting in muscle ...